STX-110

N/A

Report date: 2023/05/22 10:19:10
NME

Base Information

Drug NameSTX-110
Drug Alias NameSTX-110
ClassificationSmall molecules
Mechanisms of ActionMetabotropic glutamate receptor 5 antagonists
TargetsMetabotropic glutamate receptor 5
Therapy Area/IndicationsAutistic DisorderFragile X Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeaside Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSeaside Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutistic DisorderFragile X Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A